In a recent study published in the journal Nature Medicine, an international team of researchers evaluated the efficacy, safety, and tolerability of extended-release ketamine tablets (R-107) in adult ...
AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company based in the U.S., today announced that it has received ...
"Use of an extended-release oral dosage ketamine formulation may be advantageous compared with intranasal or intravenous dosing." HealthDay News — For patients with treatment-resistant depression, ...
(RTTNews) - Amneal Pharmaceuticals (AMRX) announced it has received FDA approval of its New Drug Application for Pyridostigmine Bromide Extended-Release Tablets USP 105 mg. PB ER 105 mg tablets are a ...
Dr. Michael Verbora the medical director of Field Trip, holds a blister pack of Ketamine lozenges at the psychedelic therapy clinic in Toronto, Ontario, Canada, on August 28, 2020. (Photo by Cole ...
Zituvimet XR is supplied in 3 extended-release tablet strengths. The Food and Drug Administration (FDA) has approved Zituvimet XR (sitagliptin and metformin hydrochloride) extended-release tablets as ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
Auvelity (dextromethorphan/bupropion) is a prescription drug that’s used to treat depression. The drug comes as an extended-release tablet. It’s usually taken ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results